European DLB consortium: diagnostic and prognostic biomarkers in dementia with Lewy bodies, a multicenter international initiative

dc.contributorPontificia Universidad Javeriana. Facultad de Medicina. Instituto de Envejecimiento
dc.creatorOppedal, Ketil
dc.creatorBorda, Miguel Germán
dc.creatorFerreira, Daniel
dc.creatorWestman, Eric
dc.creatorAarsland, Dag
dc.creatorThe European DLB Consortium
dc.date.accessioned2020-04-28T21:39:13Z
dc.date.accessioned2020-05-08T15:24:13Z
dc.date.accessioned2022-09-22T19:06:34Z
dc.date.available2020-04-28T21:39:13Z
dc.date.available2020-05-08T15:24:13Z
dc.date.available2022-09-22T19:06:34Z
dc.date.created2020-04-28T21:39:13Z
dc.date.created2020-05-08T15:24:13Z
dc.identifier1758-2024 / 1758-2032 (Electrónico)
dc.identifierhttp://hdl.handle.net/10554/48473
dc.identifierhttps://doi.org/10.2217/nmt-2019-0016
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3460890
dc.rightsAtribución-NoComercial 4.0 Internacional
dc.rightshttp://creativecommons.org/licenses/by-nc/4.0/
dc.sourceNeurodegenerative Disease Management; Vol. 9 Núm. 5 (2019)
dc.titleEuropean DLB consortium: diagnostic and prognostic biomarkers in dementia with Lewy bodies, a multicenter international initiative
dc.typeinfo:eu-repo/semantics/article


Este ítem pertenece a la siguiente institución